Skip to content
BioTrillion logo — "Data from Life. Data for Life."

BioTrillion

"Data from Life. Data for Life."

Founded 2020 United States San Francisco, United States 5 employees Seed Total: $1.00M AI, Biotechnology +4

General Information

Company Name BioTrillion
Founded Year 2020
Location United States San Francisco, United States
Employees 5
Industries AI, Biotechnology, Computer Vision +3
Funding Stage Seed
Business Model B2B, B2B2C, Platform
Revenue Model Subscription, Licensing, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with BioTrillion. To contact BioTrillion, visit biotrillion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioTrillion compare?

A PDF of BioTrillion and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioTrillion soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioTrillion

BioTrillion, a company founded in 2018 and headquartered in the United States, is at the forefront of transforming health monitoring through advanced technology. Their vision, as captured in their slogan, "Data from Life. Data for Life.", emphasizes their commitment to democratizing access to health insights.

Their innovative product, HealthySelfie™, utilizes smartphone cameras and cutting-edge AI and computer vision to deliver medical-grade diagnostics from a simple 10-second face scan. By transforming the smartphone into a diagnostic tool, BioTrillion addresses multiple sectors including telehealth, decentralized clinical trials, and insurance risk management.

The company's proprietary DiseaseSignatures™ technology analyzes biomarkers for early disease detection, validated against clinical standards and supported by globally pending patents. This positions BioTrillion as a key player in AI and digital health industries.

Their last funding, a $2.30M Seed Round in August 2018, secured support from investors such as David B. Kirk, Santosh Kumar, and Tom X Lee, along with firms like SVTC and Constellar Ventures, underscoring the potential scale and impact of BioTrillion's technology.

Business keywords: Healthtech, AI startup, Telehealth, Decentralized Clinical Trials, Insurance Risk Management, Digital Health, Mobile Health, Biometric Data, Remote Health Monitoring, Startup, Innovative Health Solutions, Clinical Validation

Services & Products

AI-powered health diagnostics
Digital health monitoring
Data collection and analysis from smartphones
Remote sharing of health insights
Detection of developing diseases

Target Customers

Health-conscious individuals Healthcare providers Tech-enabled healthcare consumers B2B partners in healthcare verticals Investors interested in digital health

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $1.00M -
01 May 2018

BioTrillion Alternatives & Competitors

View All Alternatives
BioTrillion vs

Offering seamless healthcare access from the comfort of your home with innovative wireless health mo...

6 employees
Biotechnology, Health Care
BioTrillion vs
VivoSense, Inc.
VivoSense, Inc. United States

Advancing clinical trials research and healthcare delivery with analytics & AI for all wearable sens...

Grant
42 employees
Biotechnology, Health Care
BioTrillion vs
AccendoWave
AccendoWave United States

AccendoWave - A Pain Data Company

1 employees
Biotechnology, Health Care

FAQ About BioTrillion

"Data from Life. Data for Life."
BioTrillion was founded in 2020.
BioTrillion is headquartered in San Francisco, United States.
BioTrillion operates in AI, Biotechnology, Computer Vision, Digital Health, Health Care and Life Sciences. Its work centres on Healthtech, AI startup, Telehealth and Decentralized Clinical Trials. Its customers include Health-conscious individuals, Healthcare providers and Tech-enabled healthcare consumers.
BioTrillion has a B2B, B2B2C and Platform business model. Its revenue comes from Subscription, Licensing and Usage Based.
BioTrillion has approximately 5 employees.
BioTrillion has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Seed.
BioTrillion offers: AI-powered health diagnostics, Digital health monitoring, Data collection and analysis from smartphones, Remote sharing of health insights, Detection of developing diseases.
Top alternatives and competitors to BioTrillion include Advantage Home Telehealth, VivoSense, Inc., AccendoWave, CareMonitor, BioIntelliSense, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioTrillion and Advantage Home Telehealth are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioTrillion, https://bouncewatch.com/company/biotrillion, updated 18 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout